Cancer Center Amsterdam
-
A bispecific single-domain antibody boosts autologous Vg9Vd2-T cell responses toward CD1d in chronic lymphocytic leukemia
de Weerdt, I., Lameris, R., Ruben, J. M., de Boer, R., Kloosterman, J., King, L. A., Levin, M.-D., Parren, P. W. H. I., de Gruijl, T. D., Kater, A. P. & van der Vliet, H. J., 1 Mar 2021, In: Clinical cancer research. 27, 6, p. 1744-1755 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
A bispecific antibody antagonizes prosurvival CD40 signaling and promotes Vγ9Vδ2 T cell-mediated antitumor responses in human B-cell malignancies
de Weerdt, I., Lameris, R., Scheffer, G. L., Vree, J., de Boer, R., Stam, A. G., van de Ven, R., Levin, M.-D., Pals, S. T., Roovers, R. C., Parren, P. W. H. I., de Gruijl, T. D., Kater, A. P. & van der Vliet, H. J., 1 Jan 2021, In: Cancer immunology research. 9, 1, p. 50-61 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib
de Weerdt, I., Hofland, T., Lameris, R., Endstra, S., Jongejan, A., Moerland, P. D., de Bruin, R. C. G., Remmerswaal, E. B. M., ten Berge, I. J. M., Liu, N., van der Stelt, M., Faber, L. M., Levin, M.-D., Eldering, E., Tonino, S. H., de Gruijl, T. D., van der Vliet, H. J. & Kater, A. P., 22 Nov 2018, In: Blood. 132, 21, p. 2260-2272 13 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications